Ronapreve Approved for Additional Indication as a Preventive Treatment of Symptomatic COVID-19 in Japan

Dear Investor,Please find attached a press release by Chugai:https://www.roche.com/211105eRonapreveApproval.pdf,Do not hesitate to contact us for any further questions.With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news